0001779315-19-000001.txt : 20190701 0001779315-19-000001.hdr.sgml : 20190701 20190701130814 ACCESSION NUMBER: 0001779315-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190701 DATE AS OF CHANGE: 20190701 EFFECTIVENESS DATE: 20190701 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ACRIGEN BIOSCIENCES, INC. CENTRAL INDEX KEY: 0001779315 IRS NUMBER: 833885779 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-343190 FILM NUMBER: 19932384 BUSINESS ADDRESS: STREET 1: 202 STANFORD AVENUE CITY: KENSINGTON STATE: CA ZIP: 94708 BUSINESS PHONE: 6198471193 MAIL ADDRESS: STREET 1: 202 STANFORD AVENUE CITY: KENSINGTON STATE: CA ZIP: 94708 D 1 primary_doc.xml X0708 D LIVE 0001779315 ACRIGEN BIOSCIENCES, INC. 202 Stanford Avenue Kensington CA CALIFORNIA 94708 6198471193 DELAWARE None None Corporation true 2019 David Rabuka 202 Stanford Avenue Kensington CA CALIFORNIA 94708 Executive Officer Director Promoter Joseph Bondy-Denomy 202 Stanford Avenue Kensingtson CA CALIFORNIA 94708 Director Karen Boezi 202 Stanford Avenue Kensington CA CALIFORNIA 94708 Director Biotechnology Decline to Disclose 06b false 2019-06-14 false true true Convertible Promissory Notes and preferred stock issuable upon conversion thereof. false 0 1000000 775000 225000 false 9 0 0 0 false ACRIGEN BIOSCIENCES, INC. /s/ David Rabuka David Rabuka CEO 2019-06-30